Prescription drug prices falling to 47 year low as generics rise, Amy Klobuchar wrong on talking points
The cost of prescription drugs are falling for the first time in 47 years. photo/ Andrea The government on Tuesday said prescription prices sank 1% in February, marking the biggest one-month decline ever. The cost More...
The DEA, the Kratom ban and A March of a dedicated few
On August 30th Forbes published an article revealing the DEA’s plan to ban the herbal supplement known as kratom. The governmental agency stated that kratom poses “an imminent hazard to the public safety” More...
Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee
PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...
FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections
PRESS RELEASE Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...
